Results 241 to 250 of about 186,162 (294)
Some of the next articles are maybe not open access.

Low-density lipoprotein (LDL) oxidizability before and after LDL apheresis

Metabolism, 1999
Oxidation of low-density lipoprotein (LDL) plays a major role in the development of atherosclerosis. Hypercholesterolemia has been associated with enhanced in vitro oxidation of LDL, and lipid-lowering therapy reduces LDL oxidizability. In the present study, we investigated whether LDL apheresis performed with different techniques affects in vitro ...
M G, Donner   +3 more
openaire   +2 more sources

Low density lipoprotein (LDL) binding affinity for the LDL receptor in hyperlipoproteinemia

Atherosclerosis, 1999
We measured the binding affinity of low density lipoprotein (LDL) for the LDL receptor in patients with various types of hyperlipoproteinemia and investigated the effects of LDL lipid composition and particle size on receptor affinity. LDL (1.019 < d < 1.063) was isolated by sequential ultracentrifugation from the serum of normolipidemic controls and ...
Y, Toyota   +3 more
openaire   +2 more sources

LDL receptor-independent and -dependent uptake of lipoproteins

Atherosclerosis, 1995
The liver plays a decisive role in the regulation of the plasma levels of atherogenic lipoproteins. The primary liver interaction site for chylomicron-remnants and VLDL remnants (beta-VLDL) is still unidentified, while the subsequent cellular uptake is likely to be mediated in concert by the LDL receptor related protein (LRP) and the LDL receptor.
van Berkel, T. J.   +4 more
openaire   +3 more sources

The lipoproteins selections aphereses with LDL Lipopak 400

Transfusion and Apheresis Science, 2013
The lipid lowering is one of the main ways to achieve reduction of the atherosclerosis progress. In the rare patients with homozygous familial hypercholesterolemia low density lipoprotein cholesterol apheresis should be performed as these patients usually have extremely high low density lipoprotein cholesterol concentrations and these patients usually ...
A, Griskevicius   +4 more
openaire   +2 more sources

A New Low Density Lipoprotein (LDL) Adsorbent

Artificial Cells, Blood Substitutes, and Biotechnology, 1997
Crosslinked O-Carboxymethyl (O-CM) Chitosan beads were prepared by the reaction of O-CM Chitosan with glutaraldehyde solution. Results in vitro experiments with this new developed LDL adsorbent are presented. This adsorbent is capable of cutting down LDL-Cholesterol without significantly affecting HDL and TP (Total Proteins) levels in the plasma.
Y U, Yihua, H E, Binglin
openaire   +2 more sources

Lipoprotein correlates of LDL particle size

Atherosclerosis, 2000
Correlations of low-density lipoprotein (LDL) predominant particle diameters (PPD) were investigated in samples taken from the San Antonio Family Heart Study. A frequency histogram showed LDL PPD occurs in at least two distinct modes, at about 25.5 and 26.9 nm, with the nadir at about 26.2 nm.
openaire   +2 more sources

The rebound of lipoproteins after LDL-apheresis. Effects on chemical composition and LDL-oxidizability

Atherosclerosis, 1999
The changes in low density lipoprotein (LDL) composition and oxidizability after LDL-apheresis (LA) using dextran sulfate cellulose columns were evaluated in 12 hypercholesterolemic men (mean+/-S.D. total cholesterol (TC) 9.7+/-1.8 mmol/l). After 10-20 months on biweekly LA combined with simvastatin 40 mg per day immediate pre-apheresis levels of TC ...
Kroon, A.A.   +3 more
openaire   +3 more sources

Are ‘precipitated LDL’ really low density lipoproteins?

Clinica Chimica Acta, 1987
Cholesterol, phospholipid and Apo B levels were determined in low density lipoproteins (LDL) precipitated by amphipathic polymers (Biomérieux kit, Marcy-l'Etoile, France) and compared to those of ultracentrifuged LDL. For 113 sera (triglyceride level less than 4.5 mmol/l, absence of very low density lipoproteins-remnants) LDL-cholesterol values were ...
F, Mainard, Y, Madec
openaire   +2 more sources

Lipoprotein(a) and LDL-C

Journal of the American College of Cardiology, 2022
Pamela B. Morris   +2 more
openaire   +1 more source

Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions

Atherosclerosis, 1996
The purpose of this study was to examine the effects on lipoprotein risk markers for CHD of oestradiol given alone and in combination with the androgenic progestogen, norethisterone. Eighty postmenopausal women were randomly allocated to receive oestradiol (2 mg/day) alone or with continuous norethisterone (1 mg/day).
E, Farish   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy